Clinical Trial on the Effect of Autologous Oral Mucosal Epithelial Sheet Transplantation

Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age16+
SponsorSeoul National University Hospital

About this trial

To investigate the effect of ocular surface reconstruction and assess the safety in cultivated oral mucosal epithelial cell sheet transplantation (COMET) regarding patients with cicatricial change of ocular surface.

Eligibility criteria

Qualifiers

patient with eye which has limbal stem cell deficiency and conjunctivalization of cornea

patient who shows no improvement after limbal tissue or amniotic membrane transplantation, or who has difficulty in receiving long-term immunosuppressive treatment

patient who agree this clinical trial

patient with the eyes in which best corrected visual acuity is less than counting finger

Disqualifiers

patient who has relevant corneal transparency

patient who is on the pregnancy or has a plan of pregnancy within 1 year

patient who has corneal infection

patient who has diagnosis of HBV, HCV, HIV, syphilis

Trial design

Treatments tested in this trial

  • cultivated oral mucosal epithelial sheet transplantation

Treatment groups

No treatment groups listed

Sponsors and collaborators

Seoul National University Hospital

Lead sponsor

Ministry of Health & Welfare, Korea

Collaborator